货号:A747327
同义名:
H-1152 dihydrochloride
H-1152 2HCl是一种选择性 ROCK 抑制剂,Ki 值为 1.6 nM,对 ROCK2 的 IC50 为 12 nM,且对其他激酶抑制作用较弱,广泛应用于细胞信号传导研究。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ROCK ↓ ↑ | ROCK1 ↓ ↑ | ROCK2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thiazovivin |
+
ROCK, IC50: ~0.5 μM |
98% | |||||||||||||||||
| Netarsudil HCl |
++++
ROCK, Ki: 2 nM |
99%+ | |||||||||||||||||
| Y-33075 2HCl |
++++
ROCK, IC50: 3.6 nM |
99%+ | |||||||||||||||||
| ROCK1-IN-1 |
++
ROCK, Ki: 17nM |
95% | |||||||||||||||||
| GSK429286A |
+++
ROCK1, IC50: 14 nM |
++
ROCK2, IC50: 63 nM |
99%+ | ||||||||||||||||
| Ripasudil |
++
ROCK1, IC50: 51 nM |
++
ROCK2, IC50: 19 nM |
99%+ | ||||||||||||||||
| Belumosudil |
++
ROCK2, IC50: 60 nM ROCK2, Ki: 41 nM |
99%+ | |||||||||||||||||
| Y-27632 2HCl |
++
ROCK1, Ki: 140 nM |
+
ROCK2, Ki: 300 nM |
99%+ | ||||||||||||||||
| Fasudil HCl |
+
ROCK2, Ki: 330 nM |
Rho,PKG | 98% | ||||||||||||||||
| Chroman 1 |
++++
ROCK1, IC50: 52 pM |
++++
ROCK2, IC50: 1 pM |
99% | ||||||||||||||||
| BAY-549 |
++++
ROCK1, IC50: 0.6 nM |
++++
ROCK2, IC50: 1.1 nM |
99%+ | ||||||||||||||||
| AT13148 |
+++
ROCK1, IC50: 6 nM |
+++
ROCK2, IC50: 4 nM |
PKA | 95% | |||||||||||||||
| RKI-1447 |
+++
ROCK1, IC50: 14.5 nM |
+++
ROCK2, IC50: 6.2 nM |
99%+ | ||||||||||||||||
| Hydroxyfasudil HCl |
+
ROCK1, IC50: 0.73 μM |
+
ROCK2, IC50: 0.72 μM |
PKA | 98% | |||||||||||||||
| H-1152 2HCl |
+++
ROCK2, IC50: 0.0120 μM |
PKG | 99% | ||||||||||||||||
| GSK269962A HCl |
++++
ROCK1, IC50: 1.6 nM |
+++
ROCK2, IC50: 4 nM |
99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | H-1152 dihydrochloride, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases. |
| Concentration | Treated Time | Description | References | |
| MDA-MB-468 cells | 1 μM | 24 hours | inhibited TEAD reporter activity and cell proliferation | Nat Commun. 2022 Feb 4;13(1):703 |
| MCF10A cells | 1 μM | 24 hours | inhibited TEAD reporter activity | Nat Commun. 2022 Feb 4;13(1):703 |
| PC-12 cells | 10 µM | 24 hours | Induced neurite outgrowth, formed fully extended neurites | Cell Mol Biol Lett. 2006;11(1):12-29 |
| MDA-MB-231 cells | 1 μM | 24 hours | inhibited TEAD reporter activity and cell proliferation | Nat Commun. 2022 Feb 4;13(1):703 |
| H2373 cells | 1 μM | 24 hours | inhibited TEAD reporter activity and cell proliferation | Nat Commun. 2022 Feb 4;13(1):703 |
| human umbilical vein endothelial cells (HUVECs) | 3 µM | 30 minutes | Inhibited ROCK activity, reversed CCM2 siRNA-induced MLC phosphorylation and stress fiber formation, and reduced monolayer permeability | J Exp Med. 2010 Apr 12;207(4):881-96 |
| human umbilical vein endothelial cells (HUVECs) | 3 µM | 30 minutes | Inhibited ROCK activity, reversed KRIT1 siRNA-induced MLC phosphorylation and stress fiber formation, and reduced monolayer permeability | J Exp Med. 2010 Apr 12;207(4):881-96 |
| coronary arterioles | 10^-8 M | 60 minutes | H-1152 alleviated oxidative stress and abolished enhanced vasoconstriction to ET-1 by inhibiting the ROCK signaling pathway. | Cardiovasc Res. 2017 Sep 1;113(11):1329-1337 |
| PC-12 cells | 1 µM | 5-30 minutes | Induced neurite outgrowth, observed rapid cell shape change and neurite formation | Cell Mol Biol Lett. 2006;11(1):12-29 |
| human dermal microvascular endothelial cells (HMVECs) | 20 μmol/L | 0.5 hours | H-1152 attenuated the AGE-induced alteration in monolayer permeability and cytoskeleton | Cardiovasc Diabetol. 2012 Jan 17;11:7 |
| INSw/GFPHES3 cells | 10 μM | 8 days | Promote the generation and maturation of beta-like cells in three-dimensional culture, H1152 treatment significantly increases the percentage of INS+ cells and the expression of mature beta cell markers | Nat Commun. 2017 Aug 21;8(1):298 |
| HUES8 cells | 10 μM or 1 μM | 4 days | Promote the generation of insulin-expressing cells from pancreatic progenitors, H1152 treatment significantly increases the percentage of INS+ cells | Nat Commun. 2017 Aug 21;8(1):298 |
| TKCC5 human PDAC cells | 10 µM | 1 hour | Inhibited ROCK substrate phosphorylation, reduced phosphorylation of MLC2 and MYPT1 | Cancer Res. 2018 Jun 15;78(12):3321-3336 |
| KPC mouse PDAC cells | 10 µM | 1 hour | Inhibited ROCK substrate phosphorylation, reduced phosphorylation of MLC2 and MYPT1 | Cancer Res. 2018 Jun 15;78(12):3321-3336 |
| hippocampal neurons | 100 nM | 60 minutes | blocking the RhoA effector ROCK to prevent CRH-induced loss of thin dendritic spines | Mol Psychiatry. 2013 Apr;18(4):485-96 |
| Administration | Dosage | Frequency | Description | References | ||
| SCID mice | Breast tumor xenograft model | Intraperitoneal injection | 25 mg/kg | Once daily for 31 days | Inhibited tumor growth | Nat Commun. 2022 Feb 4;13(1):703 |
| SCID-beige mice | Diabetes model | Subrenal capsule transplantation | 10 μM | Single transplantation, observed up to 4.5 months post-transplantation | Evaluate the function of H1152-treated beta-like cells in vivo, results show that H1152-treated cells have improved capacities to respond to glucose stimulation and maintain glucose homeostasis | Nat Commun. 2017 Aug 21;8(1):298 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.55mL 0.51mL 0.25mL |
12.74mL 2.55mL 1.27mL |
25.49mL 5.10mL 2.55mL |
|
| CAS号 | 871543-07-6 |
| 分子式 | C16H23Cl2N3O2S |
| 分子量 | 392.34 |
| SMILES Code | CC1=CN=CC2=C1C(S(=O)(N3[C@@H](C)CNCCC3)=O)=CC=C2.[H]Cl.[H]Cl |
| MDL No. | MFCD06411451 |
| 别名 | H-1152 dihydrochloride |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 9 mg/mL(22.94 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 35 mg/mL(89.21 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1